{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:49:06Z","timestamp":1789019346152,"version":"build-2803163510"},"reference-count":28,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>To review the experience of a dedicated paediatric multidisciplinary lipid clinic in the management of familial hypercholesterolaemia (FH) by studying the demographics, clinical presentations as well as statin therapy and outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective database review of all patients under 18\u2009years old seen in the lipid clinic at an Australian tertiary paediatric hospital between April 1999 and August 2017. Outcome measures collected included patient demographics, family history, lipid profile, age at treatment commencement, treatment outcomes and complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and eight patients (53 males) were seen in the lipid clinic. Eighty\u2010five had low\u2010density lipoprotein cholesterol (LDL\u2010C) levels at or above the 75th percentile for sex prior to treatment. Of these, 75 had a first\u2010degree relative with hypercholesterolaemia and\/or early cardiac death. Four patients had clinical manifestations. Thirty\u2010two patients (14 males) were started on statin therapy for likely FH. LDL\u2010C levels reduced by 2.4\u2009mmol\/L (1.4 to 2.7) in boys and 1.9\u2009mmol\/L (0.8 to 2.8) in girls at 12\u2009month follow\u2010up. Five patients reported side effects requiring adjustment in therapy. Main reasons for not starting statin therapy in eligible patients were parental refusal and\/or lost to follow up (77%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A dedicated multidisciplinary lipid clinic is helpful for streamlining and monitoring management of paediatric FH. Clinical manifestations of FH are rare in children and may represent more severe form of FH or other lipid disorder. Statin therapy is efficacious and well tolerated but current recommended targets of treatment are difficult to attain. Greater awareness and coordinated services are required to overcome poor family engagement.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jpc.15426","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:49:39Z","timestamp":1617886179000},"page":"1201-1207","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Familial hypercholesterolaemia: Experience of a tertiary paediatric lipid clinic"],"prefix":"10.1111","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-667X","authenticated-orcid":false,"given":"Jeffrey","family":"Yeung","sequence":"first","affiliation":[{"name":"Institute of Endocrinology and Diabetes The Children's Hospital at Westmead  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryn","family":"Chisholm","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology and Diabetes The Children's Hospital at Westmead  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Spinks","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology and Diabetes The Children's Hospital at Westmead  Sydney New South Wales Australia"},{"name":"Clinical Genetics Unit. Department of Medical Genomics Royal Prince Alfred Hospital  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology and Diabetes The Children's Hospital at Westmead  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"65","article-title":"Lipids in children and links to adult vascular disease","volume":"39","author":"Coakley JC","year":"2018","journal-title":"Clin. Biochem. Rev."},{"key":"e_1_2_7_3_1","first-page":"89","article-title":"A boy with autosomal recessive hypercholesterolaemia","volume":"62","author":"Rodenburg J","year":"2004","journal-title":"Neth. J. Med."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv157"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.11.019"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.04.003"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.12036"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht273"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2011.06.001"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2008.135"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1349"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.03.032"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003"},{"key":"e_1_2_7_14_1","first-page":"12","article-title":"The influence of menarche of high cholesterol level in adolescent girls with familial hypercholesterolemia","volume":"68","author":"Hy\u00e1nek J","year":"2013","journal-title":"Cesk. Pediatr."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.13898"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.13457"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00707"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht015"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.11.025"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.08.008"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816454"},{"key":"e_1_2_7_22_1","unstructured":"Australia Co.Summary for ARTG Entry:98626SIMVASTATIN SANDOZ simvastatin 80\u2009mg tablet bottle2020. Available from:https:\/\/www.ebs.tga.gov.au\/servlet\/xmlmillr6?dbid=ebs\/PublicHTML\/pdfStore.nsf&docid=CBC4345D13066566CA25859800422E99&agid=(PrintDetailsPublic)&actionid=1[accessed 18 August 2020]."},{"key":"e_1_2_7_23_1","unstructured":"Australia Co.Summary for ARTG Entry:98489CHOLSTAT 40 pravastatin sodium 40mg tablet blister pack2020[updated 16 July 2020]."},{"key":"e_1_2_7_24_1","unstructured":"Australia Co.Summary for ARTG Entry:322344NOUMED ATORVASTATIN atorvastatin (as calcium trihydrate) 80 mg tablets blister pack2020[updated 16 July 2020]."},{"key":"e_1_2_7_25_1","unstructured":"Australia Co.Summary for ARTG Entry:333486BLOOMS THE CHEMIST ROSUVASTATIN rosuvastatin (as calcium) 20\u2009mg tablet bottle2020[updated 16 July 2020]."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.07.011"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1946-4"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.11.012"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.09.005"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jpc.15426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jpc.15426","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jpc.15426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T01:02:37Z","timestamp":1692666157000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jpc.15426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1111\/jpc.15426"],"URL":"https:\/\/doi.org\/10.1111\/jpc.15426","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"2020-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}